2008-03-19 23:36:06 -
www.researchandmarkets.com - Research and Markets (www.researchandmarkets.com/reports/c86292) has announced the addition of Philippines Phamaceuticals & Healthcare Report Q1 2008 to their offering.
The Philippines Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on the Philippines pharmaceuticals and healthcare industry.
Until the 'Cheaper Medicine Bill' is fully approved by the legislature, we
will be maintaining our forecasts for the Philippines' US$2.61bn pharmaceutical market. The new law is expected to reduce the cost of many medicines, but lowering our projections is not planned. In fact, given that more people on low incomes will be able to afford quality healthcare products, we are more likely to upwardly revise our expectations for future sales. We are forecasting 5% year-on-year (y-o-y) growth through to 2012, when the market will have a valuation of US$4.02bn.
The Philippines has a nascent biotech sector, but there signs that expansion will occur soon. During Q407, local firm Servac Philippines has contracted Swedish company Pharmadule to build a state-of-the-art production facility. The US$120mn plant will make a vaccine for the prevention of rabies, which is a significant problem in the country. A prime indicator of the buoyant generic sector is The Generics Pharmacy, an enterprise that aims expand and extend the reach of generics to those on low incomes. Despite having only a minimal involvement with patented drugs, it is expanding rapidly. There are currently 27 outlets and the target is to have a 100 by mid-2008.
Contents:
Executive Summary
Philippines Pharmaceutical and Healthcare Industry SWOT
Philippines Political SWOT
Philippines Economic SWOT
Philippines Business Environment SWOT
The Philippines: Business Environment Ranking
Pharmaceutical Ratings - Revised Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Philippines - Pharmaceutical Business Environment Ranking
Table: Asia Pacific Pharmaceutical Business Environment Ratings
Limits of Potential Returns
Risks to Realisation Of Returns
The Philippines - Market Summary
Regulatory Regime
Table: Timeline of Cheaper Medicines Bill, 2007
Intellectual Property Regime
IP Shortcomings
IP Disputes
Counterfeit Drugs
Pricing and Reimbursement Regime
Parallel Trade
Corruption
International Co-operation
Industry Trends and Developments
Epidemiology
Healthcare Sector
Medical Tourism
Pharmaceutical Sector
Table Clinical Trial Considerations in Asia
Domestic Industry
Foreign Companies
Biotechnology
Traditional Medicines
Pharmaceutical Retail
Industry Forecast Sce
Overall Market Forecast
Table: Philippines' Pharmaceuticals Market Trends
Key Growth Factors - Industry
Table: Philippines' Health Expenditure Forecasts
Key Growth Factors - Macroeconomic
Philippines Pharmaceuticals & Healthcare Report Q1 2008
Table: Philippines - Economic Activity
Prescription Market Forecast
Table: Philippines' Prescription Drugs Market Indicators (US$mn unless otherwise stated)
OTC Market Forecast
Table: Philippines' OTC Drugs Market Indicators (US$mn unless otherwise stated)
Generics and Patented Market Forecast
Table: Philippines' Generics and Patented Market Forecasts
Export/Import Forecasts
Table: Philippines' Pharmaceuticals Exports & Imports Forecasts (US$mn)
Other Healthcare Data Forecasts
Table: Philippines Other Health Indicators
Key Risks to BMI's Forecast Scenario
Competitive Landscape.50
Table: Leading Firms and Medicines in the Philippines, Q405
Company Monitor
Leading Multinational Manufacturers
GlaxoSmithKline Philippines
Pfizer
Novartis
Merck & Co
Sanofi-Aventis
Abbott Laboratories
Bristol-Myers Squibb
Wyeth
Eli Lilly
Indigenous Manufacturers
Unilab
Pascual Laboratories
Pacific Pharmaceuticals
MediChem Pharmaceuticals
Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Sources
For more information visit
www.researchandmarkets.com/reports/c86292
Research and Markets
Laura Wood, Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com 
